Filter posts

From Treatments to Cures – BIO Partnering Sets the Stage

The fight against HIV has moved off the front pages. Advancements in antiretroviral drugs are …

More Meetings, More Results with BIO One-on-One Partnering

Innovate Biopharmaceuticals has had more meetings through BIO’s One-on-One Partnering™ than they can count. In …

Nominate Your Company to be the Buzz of BIO!

Is your company seeking a next round of financing or hoping to make the valuable …

The Strong Keep Getting Stronger: Why the Bay Area Remains #1 Biotech Hub for VC Investing

Whether you come to the Bay Area for the entrepreneurial talent, venture capital investment or …

The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network

As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial …

Influential investor, Wende Hutton, to Speak at #BIF19

In a few short months BIO will be hosting the BIO Investor Forum (#BIF19) for …

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor …

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Within the past year, the FDA has launched a provider pre-certification program as a pilot …

A Patient-Centric Approach to Investing & Partnering

Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: …

Lessons from “View from the Board: Responding to an Acquisition Offer”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO …